Broker Research
November 17, 2025 / 14:52 IST
Reported Consolidated quarterly numbers for Sun Pharma Advanced Research Company are:Net Sales at Rs 7.86 crore in September 2025 down 38.88% from Rs. 12.86 crore in September 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 75.85 crore in September 2025 up 29.33% from Rs. 107.33 crore in September 2024.
EBITDA stands negative at Rs. 65.71 crore in September 2025 up 36.12% from Rs. 102.87 crore in September 2024.
Sun Pharma Adv shares closed at 132.07 on November 13, 2025 (NSE) and has given -12.35% returns over the last 6 months and -33.09% over the last 12 months.
| Sun Pharma Advanced Research Company | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Sep'25 | Jun'25 | Sep'24 | | Net Sales/Income from operations | 7.86 | 9.64 | 12.86 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 7.86 | 9.64 | 12.86 | | EXPENDITURE | | Consumption of Raw Materials | 6.10 | 5.13 | 8.31 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 29.51 | 31.32 | 38.48 | | Depreciation | 2.56 | 2.68 | 3.16 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 37.97 | 25.27 | 68.98 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -68.28 | -54.76 | -106.07 | | Other Income | 0.01 | 9.14 | 0.04 | | P/L Before Int., Excpt. Items & Tax | -68.27 | -45.62 | -106.03 | | Interest | 7.52 | 6.19 | 1.14 | | P/L Before Exceptional Items & Tax | -75.79 | -51.81 | -107.17 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -75.79 | -51.81 | -107.17 | | Tax | 0.06 | 0.06 | 0.16 | | P/L After Tax from Ordinary Activities | -75.85 | -51.87 | -107.33 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -75.85 | -51.87 | -107.33 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -75.85 | -51.87 | -107.33 | | Equity Share Capital | 32.45 | 32.45 | 32.45 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.34 | -1.60 | -3.31 | | Diluted EPS | -2.34 | -1.60 | -3.31 | | EPS After Extra Ordinary | | Basic EPS | -2.34 | -1.60 | -3.31 | | Diluted EPS | -2.34 | -1.60 | -3.31 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
